Investigation of the human metabolism and disposition of the prolyl hydrolase inhibitor daprodustat using IV microtracer with Entero‐Test bile string
Abstract Daprodustat is an oral small molecule hypoxia‐inducible factor (HIF) prolyl hydroxylase inhibitor (PHI) approved in Japan and the United States for the treatment of anemia associated with chronic kidney disease. This phase 1, nonrandomized, 2‐period, crossover study in 6 healthy men charact...
Saved in:
Main Authors: | Guoying Tai (Author), Fangming Xia (Author), Cathy Chen (Author), Adrian Pereira (Author), Jill Pirhalla (Author), Xiusheng Miao (Author), Graeme Young (Author), Claire Beaumont (Author), Liangfu Chen (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery and characterization of naturally occurring chalcones as potent inhibitors of bile salt hydrolases
by: Chun-Yu Li, et al.
Published: (2022) -
Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney Disease
by: Ishii T, et al.
Published: (2021) -
MODIFICATION OF GUT BACTERIAL BILE SALT HYDROLASE ACTIVITY AND CARDIOVASCULAR RISK: A RANDOMIZED STUDY
by: Artem Neverovskyi, et al.
Published: (2020) -
The entero-insular axis: a journey in the physiopathology of diabetes
by: Roberta Malaguarnera, et al.
Published: (2020) -
Daprodustat: A potential game-changer in renal anemia therapy-A perspective
by: Muhammad Usman Haider, et al.
Published: (2023)